Heritage Investors Management Corp Sells 1,052 Shares of Align Technology, Inc. (NASDAQ:ALGN)

Heritage Investors Management Corp trimmed its position in shares of Align Technology, Inc. (NASDAQ:ALGN) by 7.6% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 12,759 shares of the medical equipment provider’s stock after selling 1,052 shares during the quarter. Heritage Investors Management Corp’s holdings in Align Technology were worth $2,660,000 at the end of the most recent quarter.

Other large investors have also bought and sold shares of the company. True Wealth Design LLC boosted its position in Align Technology by 10,700.0% during the 3rd quarter. True Wealth Design LLC now owns 108 shares of the medical equipment provider’s stock valued at $27,000 after acquiring an additional 107 shares in the last quarter. Neo Ivy Capital Management bought a new stake in shares of Align Technology in the 3rd quarter worth approximately $32,000. Versant Capital Management Inc boosted its position in shares of Align Technology by 212.2% in the 4th quarter. Versant Capital Management Inc now owns 231 shares of the medical equipment provider’s stock worth $48,000 after purchasing an additional 157 shares in the last quarter. Newbridge Financial Services Group Inc. bought a new stake in shares of Align Technology in the 4th quarter worth approximately $52,000. Finally, Quarry LP boosted its position in shares of Align Technology by 74.8% in the 3rd quarter. Quarry LP now owns 222 shares of the medical equipment provider’s stock worth $56,000 after purchasing an additional 95 shares in the last quarter. 88.43% of the stock is owned by institutional investors.

Analyst Ratings Changes

A number of analysts have recently commented on the company. Bank of America boosted their price target on Align Technology from $200.00 to $206.00 and gave the stock an “underperform” rating in a research report on Friday, December 13th. Morgan Stanley dropped their price target on Align Technology from $280.00 to $272.00 and set an “overweight” rating on the stock in a research report on Thursday, February 6th. Leerink Partnrs raised Align Technology from a “hold” rating to a “strong-buy” rating in a research report on Monday, January 6th. Mizuho assumed coverage on Align Technology in a research report on Wednesday, December 4th. They issued an “outperform” rating and a $295.00 price target on the stock. Finally, Leerink Partners upgraded shares of Align Technology from a “market perform” rating to an “outperform” rating and boosted their price objective for the stock from $235.00 to $280.00 in a report on Monday, January 6th. One research analyst has rated the stock with a sell rating, two have issued a hold rating, ten have issued a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, Align Technology currently has an average rating of “Moderate Buy” and an average target price of $269.91.

Align Technology Trading Down 2.8 %

Shares of ALGN opened at $185.77 on Friday. The firm has a market cap of $13.87 billion, a PE ratio of 33.11, a P/E/G ratio of 2.24 and a beta of 1.67. The firm has a fifty day simple moving average of $212.44 and a two-hundred day simple moving average of $223.57. Align Technology, Inc. has a 1-year low of $183.26 and a 1-year high of $335.40.

Align Technology (NASDAQ:ALGN) last announced its earnings results on Wednesday, February 5th. The medical equipment provider reported $1.96 earnings per share for the quarter, missing analysts’ consensus estimates of $2.43 by ($0.47). Align Technology had a net margin of 10.54% and a return on equity of 13.84%. As a group, research analysts forecast that Align Technology, Inc. will post 7.98 EPS for the current fiscal year.

Align Technology Company Profile

Align Technology, Inc designs, manufactures, and markets Invisalign clear aligners, and iTero intraoral scanners and services for orthodontists and general practitioner dentists in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers comprehensive products, including Invisalign comprehensive package that addresses the orthodontic needs of younger patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of six and ten years, which is a mixture of primary/baby and permanent teeth.